MEDOF (MEDOF) Stock Price & Analysis
MEDOF (MEDOF) rose 0.00% to USD 50 as of June 10, 2026 at 07:48 UTC, according to Nexqual real-time market data.
MEDOF last closed at USD 50; the session ranged USD 13.64–13.64 on volume of 2,000 shares. Market capitalization is $1.28B, with a 52-week range of USD 13.64–50 (PNK). Source: Nexqual, June 10, 2026 at 07:48 UTC.
Key Statistics (as of June 10, 2026 at 07:48 UTC)
| Price | USD 50 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 50 |
| Open | USD 13.64 |
| Day Range | USD 13.64 – 13.64 |
| 52-Week Range | USD 13.64 – 50 |
| Volume | 2,000 shares |
| Market Cap | $1.28B |
| Exchange | PNK |
Technical Analysis (MEDOF)
Nexqual's technical model rates MEDOF "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 07:48 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 50) |
| MACD | 0 (negative) |
Analyst Ratings (MEDOF)
Wall Street analysts rate MEDOF "None", per Nexqual as of June 10, 2026 at 07:48 UTC.
| Consensus Rating | None |
|---|
Earnings (MEDOF)
| Next Earnings Date | 2026-08-12 |
|---|
Source: Nexqual, June 10, 2026 at 07:48 UTC.
Financials & Fundamentals (MEDOF)
| Total Revenue | $2.12B |
|---|---|
| Revenue Growth (YoY) | +8.90% |
| Gross Margin | +9.40% |
| Operating Margin | +1.89% |
| Profit Margin | +0.66% |
| ROE | +2.69% |
| Debt / Equity | 33.23 |
| Current Ratio | 1.93 |
| Total Cash | $93.60M |
| Total Debt | $172.67M |
| Free Cash Flow | $74.32M |
Source: Nexqual, June 10, 2026 at 07:48 UTC.
Financial Health Score (MEDOF)
Nexqual rates MEDOF's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 07:48 UTC.
| Growth | Solid — Revenue +10% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 9%, operating 2% |
| Balance Sheet | Solid — $94M cash vs $173M debt |
| Cash Flow | Mixed — FCF $74M, slim 3.6% margin |
| Efficiency | Weak — ROE 3%, ROA 2.8% |
Ownership (MEDOF)
| Insider Ownership | +19.70% |
|---|---|
| Institutional Ownership | +51.38% |
| Shares Outstanding | 25.51M |
| Float | 8.33M |
Source: Nexqual, June 10, 2026 at 07:48 UTC.
Leadership (MEDOF)
MEDOF is led by Thomas Meier (age 57), CEO & Member of Executive Board, per Nexqual as of June 10, 2026 at 07:48 UTC.
| CEO & Member of Executive Board | Thomas Meier (age 57) |
|---|---|
| CFO & Member of the Executive Board | Stefan Bauerreis (age 53) |
Major Backers & Investors (MEDOF)
Notable institutional backers of MEDOF include DFA INVESTMENT TRUST CO-The Continental Small Company Series, according to Nexqual as of June 10, 2026 at 07:48 UTC.
Active Investors
| Investor | Stake |
|---|---|
| DFA INVESTMENT TRUST CO-The Continental Small Company Series | 0.19% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Dimensional Fund Advisors | 0.11% |
Source: Nexqual, June 10, 2026 at 07:48 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INDHF | INDUS-HOLDING AG | USD 24.45 | ▲ 0% |
| SAMHF | ALLEIMA AB | USD 8.32 | ▲ 0% |
| FBOHF | FORBO HLDGS AG | USD 839.63 | ▲ 0% |
| DFDDF | DFDS A/S Copenhagen | USD 21.5 | ▲ 26.47% |
| MNICF | Mani, Inc. | USD 12.82 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:48 UTC. This page is informational and not investment advice.